Moderna Stock Plummets 16% After £819.59M Guidance Cut Over …

1 day ago · Vaccine maker Moderna's (NASDAQ: MRNA) stock prices fell by over 16% on 13th January to close at £28.81 ($35.15) after the company trimmed its 2025 revenue guidance to …

16%
OFF

Moderna Stock Plummets 16% After £819.59M Guidance Cut Over …

2 weeks from now

1 day ago · Vaccine maker Moderna's (NASDAQ: MRNA) stock prices fell by over 16% on 13th January to close at £28.81 ($35.15) after the company trimmed its 2025 revenue guidance to …

ibtimes.co.uk

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

1 day ago · Shares of Moderna were down nearly 17% on Monday, likely due to the guidance cut. This revised guidance fell significantly below Wall Street expectations. The Zacks Consensus …

yahoo.com

17%
OFF

Moderna Crashes 17%. 'No Inflection In Sight' After Guidance Cut …

2 weeks from now

Moderna also cut its 2025 outlook and now projects just $1.5 billion to $2.5 billion, well below its prior view for $2.5 billion to $3.5 billion. Moderna stock crashed 16.8%, closing at 35.15.

msn.com

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

1 day ago · The crash in MRNA stock comes after the company slashed its outlook for 2024 and 2025 sales and also announced an expanded cost-cutting initiative. Moderna Stock Plummets …

zacks.com

$3
OFF

Moderna Shares Slide After Sales Guidance Slashed - Financial Times

2 weeks from now

2 days ago · It also said it expected to report revenues of $3bn-$3.1bn for 2024, at the lower end of previous guidance of $3bn-$3.5bn. Moderna stock fell as low as $31.94, more than 90 per …

ft.com

$3
OFF

Moderna's Stock Slides As It Slashes Research Spending, Trims Pipeline

2 weeks from now

Sep 12, 2024 · In early August, Moderna's stock suffered its biggest-ever one-day decline after the company cut its full-year 2024 sales guidance to a range of $3 billion to $3.5 billion, down …

morningstar.com

$13
OFF

Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

2 weeks from now

Nov 7, 2024 · Cambridge, Mass.-based Moderna (MRNA) had a net profit of $13 million, or 3 cents a share, for the quarter, after a loss of $3.6 billion, or $9.53 a share, in the year-earlier …

morningstar.com

21%
OFF

Moderna Crashes 21% After Slashing 2024-25 Guidance

2 weeks from now

2 days ago · Moderna also cut its 2025 outlook and now projects just $1.5 billion to $2.5 billion, well below its prior view for $2.5 billion to $3.5 billion. Moderna stock crashed 20.7% to 33.50.

investors.com

25%
OFF

Moderna Stock Plunges As Vaccine Maker Slashes R&D Budget

2 weeks from now

Sep 12, 2024 · In the release, Moderna also said it anticipates fiscal 2025 revenue to be in the range of $2.5 billion to $3.5 billion and sales to grow at a 25% compound annual growth rate …

kiplinger.com

20%
OFF

Who's To Blame As Moderna's Stock Falls Amid Slashed Guidance?

2 weeks from now

Aug 1, 2024 · Moderna shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from the …

yahoo.com

27%
OFF

Moderna Stock Lost 27% Of Its Value Over Two Days. It Just …

2 weeks from now

Aug 5, 2024 · Moderna sustained a rare downgrade on Monday following its guidance cut for the year. ... stock, which lost 27% of its value over two days ... 1/07/2025 Moderna stock surged …

investors.com

39%
OFF

Moderna Stock Down 39% In Three Months: Buy The Dip Or Wait?

2 weeks from now

Dec 23, 2024 · Alongside the guidance cut, Moderna also implemented a portfolio prioritization and cost efficiency program to reduce annual R&D expenses and focus on products that are …

nasdaq.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs - Yahoo …

2 weeks from now

Sep 12, 2024 · Moderna Expects FDA Approval of 10 New Products Over the Next 3 Years. Moderna said Thursday that based on current trial data, it expects to receive Food and Drug …

yahoo.com

20%
OFF

Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance …

2 weeks from now

2 days ago · Shares of Moderna, Inc. plunged over 20% on Monday to their lowest levels since mid-April 2020 and were on course to mark their worst day on record. This sharp decline …

stocktwits.com

21%
OFF

Why Moderna Stock Just Crashed 21% - Nasdaq

2 weeks from now

2 days ago · Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET …

nasdaq.com

1%
OFF

Moderna Stock Plummets On Cost-Cutting Measures

2 weeks from now

Sep 12, 2024 · The stock has continued to move lower since its 21.1% post-earnings drop on August 1, and is currently down 35.4% year to date. Options traders are chiming in on the drop.

schaeffersresearch.com

16%
OFF

Moderna Stock Plunges After Cutting Sales Forecast For Covid-19 …

2 weeks from now

Nov 4, 2021 · By Dhirendra Tripathi. Investing.com – Moderna stock (NASDAQ:MRNA) slumped more than 16% on Thursday after the company made a sizeable cut to its guidance for sales …

yahoo.com

FAQs about Moderna Stock Plummets 16% After £819.59M Guidance Cut Over … Coupon?

Why did Moderna stock fall 17% on Monday?

Shares of Moderna were down nearly 17% on Monday, likely due to the guidance cut. This revised guidance fell significantly below Wall Street expectations. The Zacks Consensus Estimate for 2025 revenues is $2.94 billion. In the past year, the stock has plunged nearly 67% compared with the industry’s 16.3% fall. ...

Why did Moderna stock drop 2024?

Moderna (MRNA) shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from the European Union. The company said it now expects total sales between $3 billion and $3.5 billion for the year. That's down from the $4 billion forecast in the first quarter. ...

Why did Moderna stock tumble?

Sign in Moderna shares tumbled after the pharmaceutical company lowered its sales guidance due to weaker demand for its Covid-19 vaccines. Moderna now projects 2024 net sales of between $3 billion and $3.5 billion, versus previous guidance of about $4 billion, citing an increasingly competitive environment ...

Why is Moderna (mRNA) stock plunging?

Moderna (MRNA) stock is plunging Thursday after the COVID-19 vaccine maker announced plans to slash research and development (R&D) expenses and instead focus on receiving approvals for the many drugs in its pipeline. Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. ...

How much did Moderna make in 2024?

Moderna reported unaudited/preliminary product sales between $3 billion and $3.1 billion for 2024. This includes more than $3 billion in COVID-19 vaccine sales and minimal sales from the RSV vaccine mResvia. This figure was mainly toward the lower end of the company’s previously issued guidance of $3.0-$3.5 billion. ...

Will Moderna cut costs by $1.1 billion by 2027?

Moderna said it expects the moves to lower expenses by $1.1 billion by 2027. Moderna (MRNA) shares tumbled in pre-market trading Thursday as the company said it plans to cut costs and suspend or end development of some products as it focuses on later-stage trials. ...